By: Editorial Staff, Date: June 16th, 2022
The use of biometrics has redefined the norm of human authentication across different industries today. However, it has also raised some privacy challenges.
Take a quick look below!
Click here to learn more about our upcoming webcast on BIPA Class Action Litigation
Upcoming Webcasts
Ahmed Zidan2022-12-27T22:11:11-05:00 
Navigating Antitrust Issues in the Pharmaceutical and Life Science Industries: Key Trends and Challenges Explored
Price fixing, industry consolidation, and other anti-competitive business practices have long been the subject of intense antitrust scrutiny. To address these perceived flaws and abuses, President Biden issued an executive order on “Promoting Competition in the American Economy,” which calls for measures to ensure the strict enforcement of antitrust laws across several key industries, particularly in healthcare and life sciences.